Note: Six companies listed as MNTA’s peers one year ago are no longer on the list; they are: Altus Pharmaceuticals, Ariad Pharmaceuticals, Aspreva Pharmaceuticals, Atherogenics, CombinatoRx, Cytokinetics, and Pharmion.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”